Roche Gains Place in NASH Race with Purchase of Jecure Therapeutics | Enterpreneurship

0
Want create site? Find Free WordPress Themes and plugins.

Want create site? Find Free WordPress Themes and plugins.

is acquiring San Diego startup , with hopes of turning ’s early research into a drug or drugs that treat the liver disease .

Through its South San Francisco, CA-based Genentech division, the Swiss pharmaceutical giant will acquire Jecure, whose work has yet to reach clinical studies, the companies announced Tuesday. No financial terms were disclosed, but a Genentech spokesman said it was an all-cash deal.

Nonalcoholic steatohepatitis, or NASH, is a serious form of fatty liver disease that causes inflammation and scarring in the organ. There are no FDA-approved drugs for NASH, and in cases where the condition… Read more »


UNDERWRITERS AND PARTNERS


Did you find apk for android? You can find new Free Android Games and apps.
Did you find apk for android? You can find new Free Android Games and apps.

You might also like More from author

Leave A Reply

Your email address will not be published.